Evidence map›Paper›PMID 33820881›Full record

ArticleBiomolecules & therapeutics2021

Suppression of Lipopolysaccharide-Induced Inflammatory and Oxidative Response by 5-Aminolevulinic Acid in RAW 264.7 Macrophages and Zebrafish Larvae.

Seon Yeong Ji, Hee-Jae Cha, Ilandarage Menu Neelaka Molagoda, Min Yeong Kim, So Young Kim, Hyun Hwangbo, Hyesook Lee, Gi-Young Kim, Do-Hyung Kim, Jin Won Hyun and 4 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Biomolecules & therapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Seon Yeong JiAnti-Aging Research Center, Dong-eui University, Busan 47340, Republic of Korea.
Hee-Jae ChaDepartment of Parasitology and Genetics, College of Medicine, Kosin University, Busan 49104, Republic of Korea.
Ilandarage Menu Neelaka MolagodaDepartment of Marine Life Sciences, Jeju National University, Jeju 63243, Republic of Korea.
Min Yeong KimAnti-Aging Research Center, Dong-eui University, Busan 47340, Republic of Korea.
So Young KimAnti-Aging Research Center, Dong-eui University, Busan 47340, Republic of Korea.
Hyun HwangboAnti-Aging Research Center, Dong-eui University, Busan 47340, Republic of Korea.
Hyesook LeeAnti-Aging Research Center, Dong-eui University, Busan 47340, Republic of Korea.
Gi-Young KimDepartment of Marine Life Sciences, Jeju National University, Jeju 63243, Republic of Korea.
Do-Hyung KimDepartment of Aquatic Life Medicine, Pukyong National University, Busan 48513, Republic of Korea.
Jin Won HyunDepartment of Biochemistry, College of Medicine, Jeju National University, Jeju 63243, Republic of Korea.
Heui-Soo KimDepartment of Biological Sciences, Pusan National University, Busan 46241, Republic of Korea.
Suhkmann KimDepartment of Chemistry, Pusan National University, Busan 46241, Republic of Korea.
Cheng-Yun JinSchool of Pharmaceutical Sciences, Zhengzhou University, Henan 450001, China.
Yung Hyun ChoiAnti-Aging Research Center, Dong-eui University, Busan 47340, Republic of Korea.
Dong-Eui University · KRJeju National University · KRPusan National University · KRKosin University · KRPukyong National University · KRZhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we investigated the inhibitory effect of 5-aminolevulinic acid (ALA), a heme precursor, on inflammatory and oxidative stress activated by lipopolysaccharide (LPS) in RAW 264.7 macrophages by estimating nitric oxide (NO), prostaglandin E2 (PGE2), cytokines, and reactive oxygen species (ROS). We also evaluated the molecular mechanisms through analysis of the expression of their regulatory genes, and further evaluated the anti-inflammatory and antioxidant efficacy of ALA against LPS in the zebrafish model. Our results indicated that ALA treatment significantly attenuated the LPS-induced release of pro-inflammatory mediators including NO and PGE2, which was associated with decreased inducible NO synthase and cyclooxygenase-2 expression. ALA also inhibited the LPS-induced expression of pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6, reducing their extracellular secretion. Additionally, ALA abolished ROS generation, improved the mitochondrial mass, and enhanced the expression of heme oxygenase-1 (HO-1) and the activation of nuclear translocation of nuclear factor-E2-related factor 2 (Nrf2) in LPS-stimulated RAW 264.7 macrophages. However, zinc protoporphyrin, a specific inhibitor of HO-1, reversed the ALA-mediated inhibition of pro-inflammatory cytokines production and activation of mitochondrial function in LPS-treated RAW 264.7 macrophages. Furthermore, ALA significantly abolished the expression of LPS-induced pro-inflammatory mediators and cytokines, and showed strong protective effects against NO and ROS production in zebrafish larvae. In conclusion, our findings suggest that ALA exerts LPS-induced anti-inflammatory and antioxidant effects by upregulating the Nrf2/HO-1 signaling pathway, and that ALA can be a potential functional agent to prevent inflammatory and oxidative damage.

Indexed as

5-Aminolevulinic acidInflammationNrf2/HO-1ROS

Identifiers

PMID33820881
PMCPMC8551728
OpenAlexW3149921600

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.